| Phase I study of cabozantinib and nivolumab alone or with ipilimumab for advanced or metastatic urothelial carcinoma and other genitourinary tumors AB Apolo, R Nadal, DM Girardi, SA Niglio, L Ley, LM Cordes, ... Journal of Clinical Oncology 38 (31), 3672-3684, 2020 | 108 | 2020 |
| Discussing prognosis: balancing hope and realism TC Campbell, EC Carey, VA Jackson, B Saraiya, HB Yang, AL Back, ... The Cancer Journal 16 (5), 461-466, 2010 | 99 | 2010 |
| End‐of‐life planning and its relevance for patients' and oncologists' decisions in choosing cancer therapy B Saraiya, S Bodnar‐Deren, E Leventhal, H Leventhal Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 45 | 2008 |
| Impact of pathologic lymph node‐positive renal cell carcinoma on survival in patients without metastasis: Evidence in support of expanding the definition of stage IV kidney cancer A Srivastava, Z Rivera‐Núñez, S Kim, J Sterling, NJ Farber, KD Radadia, ... Cancer 126 (13), 2991-3001, 2020 | 31 | 2020 |
| A multi-institutional phase 2 study of imatinib mesylate and gemcitabine for first-line treatment of advanced pancreatic cancer RA Moss, D Moore, MF Mulcahy, K Nahum, B Saraiya, S Eddy, M Kleber, ... Gastrointestinal Cancer Research: GCR 5 (3), 77, 2012 | 25 | 2012 |
| Interventions to improve prognostic understanding in advanced stages of life-limiting illness: a systematic review LS George, K Matsoukas, DC McFarland, JM Bowers, MJ Doherty, ... Journal of pain and symptom management 63 (2), e212-e223, 2022 | 19 | 2022 |
| Sequential topoisomerase targeting and analysis of mechanisms of resistance to topotecan in patients with acute myelogenous leukemia B Saraiya, M Gounder, J Dutta, A Saleem, C Collazo, L Zimmerman, ... Anti-cancer drugs 19 (4), 411-420, 2008 | 18 | 2008 |
| Delaying surgery for clinical T1b-T2bN0M0 renal cell carcinoma: Oncologic implications in the COVID-19 era and beyond A Srivastava, HV Patel, S Kim, B Shinder, J Sterling, AL Tabakin, ... Urologic Oncology: Seminars and Original Investigations 39 (5), 247-257, 2021 | 17 | 2021 |
| Anterior Mediastinal Mass in a Young Marijuana Smoker: A Rare Case of Small-Cell Lung Cancer JP Kothadia, S Chhabra, A Marcus, M May, B Saraiya, SK Jabbour Case Reports in Medicine 2012, 2012 | 17 | 2012 |
| Cabozantinib plus nivolumab phase I expansion study in patients with metastatic urothelial carcinoma refractory to immune checkpoint inhibitor therapy DM Girardi, SA Niglio, A Mortazavi, R Nadal, P Lara, SK Pal, B Saraiya, ... Clinical Cancer Research 28 (7), 1353-1362, 2022 | 15 | 2022 |
| Retroperitoneal lymph node dissection as primary treatment for men with testicular seminoma: utilization and survival analysis using the national cancer data base, 2004-2014 AL Tabakin, BM Shinder, S Kim, Z Rivera-Nunez, CF Polotti, PK Modi, ... Clinical Genitourinary Cancer 18 (2), e194-e201, 2020 | 15 | 2020 |
| Angiosarcoma of small bowel presenting with obstruction: novel observations on a rare diagnostic entity with unique clinical presentation R Siderits, F Poblete, B Saraiya, C Rimmer, A Hazra, L Aye Case Reports in Gastrointestinal Medicine 2012 (1), 480135, 2012 | 15 | 2012 |
| Communication skills for discussing treatment options when chemotherapy has failed B Saraiya, R Arnold, JA Tulsky The Cancer Journal 16 (5), 521-523, 2010 | 15 | 2010 |
| A phase I study of combination olaparib and radium-223 in men with metastatic castration-resistant prostate cancer (mCRPC) with bone metastases (COMRADE) E Pan, W Xie, A Ajmera, A Araneta, C Jamieson, E Folefac, A Hussain, ... Molecular cancer therapeutics 22 (4), 511-518, 2023 | 14 | 2023 |
| Factors associated with palliative intervention utilization for metastatic renal cell carcinoma HV Patel, S Kim, A Srivastava, BM Shinder, J Sterling, B Saraiya, ... Clinical Genitourinary Cancer 20 (3), 296-296. e9, 2022 | 14 | 2022 |
| A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors AW Silk, B Saraiya, R Groisberg, N Chan, K Spencer, E Girda, W Shih, ... European Journal of Medical Research 27 (1), 107, 2022 | 11 | 2022 |
| Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy IY Kim, A Mitrofanova, S Panja, J Sterling, A Srivastava, J Kim, S Kim, ... Prostate International 10 (2), 75-79, 2022 | 9 | 2022 |
| A phase I/II study of combination olaparib and radium-223 in men with metastatic castration-resistant prostate cancer with bone metastases (COMRADE): A trial in progress. J Shaya, W Xie, B Saraiya, M Parikh, E Folefac, AC Olson, AD Choudhury, ... Journal of Clinical Oncology 39 (6_suppl), TPS182-TPS182, 2021 | 9 | 2021 |
| Similar incidence of DNA damage response pathway alterations between clinically localized and metastatic prostate cancer IE Kim, S Kim, A Srivastava, B Saraiya, T Mayer, WJ Kim, IY Kim BMC urology 19, 1-6, 2019 | 9 | 2019 |
| Facilitating psychological adjustment for breast cancer patients through empathic communication and uncertainty reduction E Broadbridge, K Greene, MK Venetis, LE Lee, SC Banerjee, B Saraiya, ... Patient education and counseling 114, 107791, 2023 | 8 | 2023 |
Arnav SrivastavaDepartment of Urology, University of Michigan在 med.umich.edu 的电子邮件经过验证
